UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antitumor Effects of Paeoniflorin on Hippo Signaling Pathway in Gastric Cancer Cells

Journal of oncology, 2021, Vol.2021, p.4724938-12

2021

Volltextzugriff (PDF)

Needs and Self-Care Efficacy for Cancer Patients Suffering from Side Effects of Chemotherapy

Journal of oncology, 2021, Vol.2021, p.8880366-9

2021

Volltextzugriff (PDF)

Genomic Mutations of Primary and Metastatic Lung Adenocarcinoma in Chinese Patients

Journal of oncology, 2020, Vol.2020 (2020), p.1-9

2020

Volltextzugriff (PDF)

Expression of Tumour-Associated MUC1 Is a Poor Prognostic Marker in Breast Cancer in Kumasi, Ghana

Journal of oncology, 2020, Vol.2020 (2020), p.1-7

2020

Volltextzugriff (PDF)

Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect

Nature reviews. Clinical oncology, 2016-11, Vol.13 (11), p.659-673

2016

Volltextzugriff (PDF)

Precision Detection Technology: Equipping Precision Oncology with Wings

Journal of oncology, 2020, Vol.2020 (2020), p.1-8

2020

Volltextzugriff (PDF)

CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma

Journal of oncology, 2020, Vol.2020 (2020), p.1-10

2020

Volltextzugriff (PDF)

The pharmacological bases of the antiangiogenic activity of paclitaxel

Angiogenesis (London), 2013-07, Vol.16 (3), p.481-492

2013

Volltextzugriff (PDF)

Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?

Critical reviews in oncology/hematology, 2012-04, Vol.82 (1), p.40-50

2012

Volltextzugriff (PDF)

EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis

Cancer and metastasis reviews, 2012-12, Vol.31 (3-4), p.753-761

2012

Volltextzugriff (PDF)

John Hunter and the origin of the term “angiogenesis”

Angiogenesis (London), 2016-04, Vol.19 (2), p.255-256

2016

Volltextzugriff (PDF)

Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer

Medical oncology (Northwood, London, England), 2020-03, Vol.37 (3), p.19-19, Article 19

2020

Volltextzugriff (PDF)

Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer

Oncotarget, 2015-12, Vol.6 (40), p.42396-42410

2015

Volltextzugriff (PDF)

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells

Frontiers in oncology, 2019-11, Vol.9, p.1202-1202

2019

Volltextzugriff (PDF)

Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data

Cancer letters, 2018-09, Vol.432, p.28-37

2018

Volltextzugriff (PDF)

Thrombospondin 1, a Mediator of the Antiangiogenic Effects of Low-Dose Metronomic Chemotherapy

Proceedings of the National Academy of Sciences - PNAS, 2003-10, Vol.100 (22), p.12917-12922

2003

Volltextzugriff (PDF)

Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients

Pharmacological research, 2022-07, Vol.181, p.106290-106290, Article 106290

2022

Volltextzugriff (PDF)

Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer

Cancer letters, 2017-12, Vol.411, p.35-43

2017

Volltextzugriff (PDF)

Healthcare professionals and pharmacovigilance of pediatric adverse drug reactions: a 5-year analysis of Adverse Events Reporting System Database of the Food and Drug Administration

Minerva Pediatrics, 2022-06, Vol.74 (3), p.272

2022

Volltextzugriff (PDF)

Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach

Pharmaceuticals (Basel, Switzerland), 2021-09, Vol.14 (10), p.995

2021

Volltextzugriff (PDF)

Pharmacodynamic biomarkers in metronomic chemotherapy: multiplex cytokine measurements in gastrointestinal cancer patients

Clinical and experimental medicine, 2021-02, Vol.21 (1), p.149-159

2021

Volltextzugriff (PDF)

Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward

Angiogenesis, 2015-10, Vol.18 (4), p.397-432

2015

Volltextzugriff (PDF)

Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo

Oncology reports, 2018-05, Vol.39 (5), p.2225-2234

2018

Volltextzugriff (PDF)

A 5-Year Study of Lithium and Valproic Acid Drug Monitoring in Patients with Bipolar Disorders in an Italian Clinical Center

Pharmaceuticals (Basel, Switzerland), 2022-01, Vol.15 (1), p.105

2022

Volltextzugriff (PDF)

All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma

Cancer chemotherapy and pharmacology, 2020-12, Vol.86 (6), p.841-846

2020

Volltextzugriff (PDF)

1 – 25 von 247

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(221)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Englisch
(247)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antitumor Effects of Paeoniflorin on Hippo Signaling Pathway in Gastric Cancer Cells

Needs and Self-Care Efficacy for Cancer Patients Suffering from Side Effects of Chemotherapy

Genomic Mutations of Primary and Metastatic Lung Adenocarcinoma in Chinese Patients

Expression of Tumour-Associated MUC1 Is a Poor Prognostic Marker in Breast Cancer in Kumasi, Ghana

Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect

Precision Detection Technology: Equipping Precision Oncology with Wings

CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma

The pharmacological bases of the antiangiogenic activity of paclitaxel

Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?

EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis

John Hunter and the origin of the term “angiogenesis”

Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer

Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells

Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data

Thrombospondin 1, a Mediator of the Antiangiogenic Effects of Low-Dose Metronomic Chemotherapy

Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients

Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer

Healthcare professionals and pharmacovigilance of pediatric adverse drug reactions: a 5-year analysis of Adverse Events Reporting System Database of the Food and Drug Administration

Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach

Pharmacodynamic biomarkers in metronomic chemotherapy: multiplex cytokine measurements in gastrointestinal cancer patients

Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward

Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo

A 5-Year Study of Lithium and Valproic Acid Drug Monitoring in Patients with Bipolar Disorders in an Italian Clinical Center

All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma

Suchergebnisse filtern